Navigating Weight Loss: When Will the Starter Dose of Wegovy Be Available and Your Personalized Path Forward

Last reviewed: July 9, 2026

Last updated: July 9, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Patients seeking Wegovy starter doses often encounter weeks-long delays due to supply chain constraints and high demand for GLP-1 receptor agonists. PlexusDx bridges this gap by providing immediate access to pharmaceutical-grade compounded semaglutide and tirzepatide from licensed 503A compounding pharmacies, paired with personalized genetic testing to optimize your specific weight loss pathway.

Why GLP-1 Starter Doses Face Availability Challenges

Wegovy shortages stem from unprecedented demand for GLP-1 medications combined with limited manufacturing capacity at brand-name suppliers. FDA-approved injectable semaglutide doses, particularly the 0.25 mg starter injection, have experienced intermittent stock issues since 2023. This gap has created a critical access problem for patients ready to begin treatment but unable to obtain their first dose on schedule.

Compounding pharmacies licensed under FDA Section 503A provide a legally compliant alternative path forward. These facilities prepare personalized GLP-1 medications under the same pharmaceutical standards as manufactured versions, ensuring sterility, potency, and safety without the brand-name supply bottleneck. PlexusDx partners exclusively with licensed 503A compounding pharmacies to guarantee consistent availability across all 50 states.

Compounded GLP-1 Medications vs. Branded Alternatives: What You Should Know

Compounded semaglutide and tirzepatide contain identical active pharmaceutical ingredients to their branded counterparts like Wegovy and Zepbound, but are formulated by licensed pharmacy experts in real-time. This means no waiting lists, no manufacturing delays, and personalized dosing from your first month of treatment. PlexusDx delivers compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan—significantly more accessible than brand-name pricing, which often exceeds $900 monthly.

The clinical mechanism remains unchanged: GLP-1 receptor activation reduces appetite, slows gastric emptying, and improves blood sugar control. Research published in obesity journals confirms compounded injectable medications achieve the same pharmacological effects as branded versions when prepared by certified compounding pharmacies. Your dose may need to go up over time—PlexusDx pricing stays flat regardless of dosage adjustments, offering transparent cost predictability.

How Genetic Testing Personalizes Your Weight Loss Therapy

Not every patient responds identically to GLP-1 therapy, and genetics play a measurable role in how your body processes and responds to semaglutide or tirzepatide. PlexusDx Precision Peptide Genetic Test analyzes key variants including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—genetic markers that directly influence appetite regulation, metabolic efficiency, and medication responsiveness. This peptide-pathway genetic analysis maps 14 biological pathways, 49 specific peptides, and 150+ actionable genetic insights.

Your genetic profile guides medication selection and optimization strategy. A patient with specific FTO variants may show stronger response to tirzepatide (a dual GIP/GLP-1 agonist) than semaglutide alone, while another individual with distinct GLP1R markers might achieve excellent results with oral semaglutide. The Precision Peptide Genetic Test costs just $298, providing personalized data that prevents months of trial-and-error dosing.

PlexusDx Access: Starting Your Personalized GLP-1 Journey Today

PlexusDx eliminates waiting by delivering compounded GLP-1 medications directly to your door across all 50 states—no insurance required, no membership fees, and HSA/FSA eligible. Your initial medication choice might be compounded semaglutide injection ($189/month), oral semaglutide ($289/month), compounded tirzepatide ($289/month), or the innovative GLP-Squared dual-compound option at $289/mo month-to-month, or from $249/mo on the 3-month plan. Starter dosing begins immediately based on your medical history and goals.

After 30 days of therapy, the Precision Peptide Genetic Test ($298) provides deep insights into your individual peptide pathway function. These results inform your dose escalation timeline and may recommend medication adjustments to maximize your personal weight loss outcomes. Monthly pricing remains flat—your dose may increase, but your cost stays consistent, enabling you to plan finances with certainty.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Precision Peptide Genetic Test is $298. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

When will Wegovy starter doses become available again?

Wegovy supply constraints remain unpredictable due to manufacturing capacity limitations. Rather than waiting, PlexusDx provides access to clinically equivalent compounded semaglutide injections immediately—at $189/mo month-to-month, or from $149/mo on the 6-month plan with no waiting list or supply delays.

Are compounded GLP-1 medications as effective as branded versions like Wegovy?

Yes. Compounded semaglutide and tirzepatide contain identical active ingredients to branded medications when prepared by licensed 503A compounding pharmacies. Clinical outcomes match branded alternatives, with the added benefit of immediate availability and lower cost.

How much does PlexusDx personalized GLP-1 therapy cost?

PlexusDx compounded semaglutide is $189/mo month-to-month, or from $149/mo on the 6-month plan, tirzepatide at $289/month, and dual GLP-Squared therapy at $289/mo (or $249/mo on the 3-month plan). All pricing remains flat regardless of dose level adjustments. The Precision Peptide Genetic Test is available for $298.

What happens if I experience side effects on my current GLP-1 dose?

Side effects like nausea typically diminish within 2–3 weeks as your body adapts. If they persist, your PlexusDx provider may adjust your dose, switch your medication formulation (injection to oral, for example), or recommend dose timing changes. Genetic insights from the Precision Peptide test can help identify whether an alternative GLP-1 compound suits your biology better.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

The Precision Peptide Genetic Test identifies variants in GIPR and FTO, and MC4R genes that influence appetite signaling and metabolic response. These insights help your provider determine whether you'll likely respond stronger to semaglutide alone, tirzepatide's dual-agonist approach, or microdose protocols. Testing is $298 and is completed after your first month of treatment.

Related Reading

• Wegovy For Weight Loss 2
• Wegovy Weight Loss Pills
• Wegovy Vs Zepbound Weight Loss
• Wegovy Weight Loss

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.